Technical Analysis for ZLAB - Zai Lab Limited

Grade Last Price % Change Price Change
F 18.08 -2.11% -0.39
ZLAB closed down 2.11 percent on Monday, March 18, 2024, on 52 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -2.11%
Stochastic Reached Oversold Weakness -2.11%
Gapped Down Weakness -2.11%
Oversold Stochastic Weakness -2.11%
Fell Below 20 DMA Bearish -7.52%
Hammer Candlestick Bullish -7.52%
Gapped Down Weakness -7.52%

   Recent Intraday Alerts

Alert Time
Up 2% about 10 hours ago
Fell Below Lower Bollinger Band about 11 hours ago
60 Minute Opening Range Breakdown about 12 hours ago
Down 2 % about 12 hours ago
Down 1% about 12 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Zai Lab Ltd, incorporated on March 28, 2017, is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Natural Sciences Infectious Diseases Medication Chemical Substances Autoimmune And Infectious Diseases

Is ZLAB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.4199
52 Week Low 17.685
Average Volume 665,480
200-Day Moving Average 25.46
50-Day Moving Average 21.45
20-Day Moving Average 19.93
10-Day Moving Average 19.26
Average True Range 1.24
RSI (14) 38.65
ADX 18.54
+DI 22.41
-DI 30.26
Chandelier Exit (Long, 3 ATRs) 19.17
Chandelier Exit (Short, 3 ATRs) 21.67
Upper Bollinger Bands 21.94
Lower Bollinger Band 17.91
Percent B (%b) 0.04
BandWidth 20.20
MACD Line -0.70
MACD Signal Line -0.65
MACD Histogram -0.0515
Fundamentals Value
Market Cap 1.78 Billion
Num Shares 98.7 Million
EPS -3.10
Price-to-Earnings (P/E) Ratio -5.83
Price-to-Sales 7.25
Price-to-Book 2.09
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.16
Resistance 3 (R3) 19.24 18.96 18.98
Resistance 2 (R2) 18.96 18.68 18.92 18.92
Resistance 1 (R1) 18.52 18.52 18.38 18.44 18.86
Pivot Point 18.24 18.24 18.17 18.20 18.24
Support 1 (S1) 17.80 17.96 17.66 17.72 17.30
Support 2 (S2) 17.52 17.80 17.48 17.24
Support 3 (S3) 17.08 17.52 17.18
Support 4 (S4) 17.00